The Global BloodGas Analyzers Market, by Product Type (Bench Top and Portable), byApplication (Anesthesia, Cardiovascular Surgery, ICU, and Others), and byRegion (North America, Latin America, Europe, Asia Pacific, Middle East, andAfrica) was valued at US$ 594.6 million in 2017 and is projected to exhibit aCAGR of 5.5% over the forecast period (2018 - 2026).
In emergency and critical caresettings blood tests, which specifically include provision of blood gases canimprove clinical decision-making and patient outcomes. Several hospitals haveimplemented bedside testing for blood gases either on an institutional level ormore commonly, in selected patient care settings such as pulmonary unit,emergency department, and neonatal intensive care.
This reduces operational cost andimproves staff efficiency, which may further enhance clinical outcomes.Technological advancements in blood gas analyzers such as easy to operate andready to use features are boosting their adoption in medical settings.Increasing demand for Point-of-Care (PoC) testing leads to fast and accurateblood gas analysis.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2603
Key market players are focused ondeveloping portable blood gas analyzers in order to increase usability andcomfort. For instance, in April 2018, Radiometer Limited launched its CE-markedpoint-of-care tests for creatinine and urea, which is the latest additions tothe ABL90 FLEX PLUS blood gas analyzer’s test menu. The versatile ABL90 FLEXPLUS is considered to be the only compact blood gas analyzer in the market tooffer such an extensive range of critical care parameters including blood gas,electrolytes, metabolites, and co-oximetry.
Moreover, in 2015, SphereMedical, launched arterial blood gas analyzer, Proxima System in Europe. Thedevice delivers efficient PoC testing as it offers frequent blood gasmeasurements at the patient’s bedside. This facilitates effective and timelyclinical decisions for proactive critical care.
Browse 32 Market Data Tables and21 Figures spread through 153 Pages and in-depth TOC on "Blood GasAnalyzers Market, by Product Type (Bench Top and Portable), by Application(Anesthesia, Cardiovascular Surgery, ICU, and Others), and by Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa) - GlobalForecast to 2026"
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/blood-gas-analyzers-market-2603
Key Takeaways of the Blood gasanalyzers Market:
The global blood gas analyzersmarket is expected to expand at a CAGR of 5.5% during the forecast period,owing to increasing demand for PoC testing.
Among product type, the portableblood gas analyzer segment is expected to witness highest growth rate in 2026,due to ease of use provided by these devices in comparison to bench topproducts
Major players operating in theglobal blood gas analyzers market include, Abbott Laboratories, Alere, Inc.,Bayer AG, Dalko Diagnostics, GE Healthcare, Instrumentation Laboratory, NovaBiomedical, Radiometer, Roche Diagnostics, Siemens Healthcare, and SphereMedical
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2603
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
